The Registry of Toxic Effects of Chemical Substances
Polychlorinated biphenyl (aroclor 1254) |
UPDATE: May 2005 | MW: N/R | MF: N/R |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
chicken
embryo
|
1 mg/L/48 hour
|
REPTED 19,79,2004
|
cytogenetic analysis
|
intraperitoneal | other fish
50 mg/kg
|
CBPCEE 82,489,1985
|
DNA adduct
|
human
liver
|
60 µmol/L/24 hour
|
TXAPA9 188,81,2003
|
DNA damage
|
oral | rat
1,295 mg/kg
|
BSIBAC 57,407,1981
|
DNA damage
|
intraperitoneal | rat
500 mg/kg
|
BSIBAC 57,407,1981
|
DNA damage
|
rat
liver
|
300 µmol/L
|
SinJF# 26OCT1982
|
unscheduled DNA synthesis
|
rat
liver
|
20 mg/L
|
CNREA8 42,3010,1982
|
micronucleus test
|
intraperitoneal | other fish
50 mg/kg
|
CYTBAI 47,147,1986
|
morphological transform
|
mouse
fibroblast
|
5 mg/L/21 day (-enzymatic activation step)
|
EMMUEG 37,231,2001
|
morphological transform
|
oral | rat
25 ppm/2 year- continuous
|
EVHPAZ 60,89,1985
|
sperm morphology
|
oral | other insects
808 mg
|
CYTBAI 11,167,1974
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | rat
lowest published toxic dose: 250 mg/kg (15 day pregnant)
|
Reproductive: Other effects on female | Reproductive: Effects on newborn: Biochemical and metabolic
IJBOBV 25,1209,1993
|
oral | mammal (species unspecified)
lowest published toxic dose: 14 mg/kg (30 day prior to copulation)
|
Reproductive: Effects on fertility: Female fertility index (e.g., # females pregnant per # sperm positive females; # females pregnant per # females mated)
|
TOXID9 4,83,1984
|
oral | mouse
lowest published toxic dose: 59,400 µg/kg (3 day prior to copulation-21 day after birth)
|
Reproductive: Effects on newborn: Behavioral
|
NTOTDY 3,5,1981
|
oral | mouse
lowest published toxic dose: 222 mg/kg (6-21 day pregnant/21 day after birth)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Effects on newborn: Behavioral Reproductive: Effects on newborn: Physical
NRTXDN 23,375,2002
|
oral | mouse
lowest published toxic dose: 252 mg/kg (1-21 day pregnant/21 day after birth)
|
Reproductive: Effects on newborn: Behavioral | Reproductive: Effects on newborn: Physical Reproductive: Effects on newborn: Other postnatal measures or effects
NRTXDN 23,375,2002
|
oral | rat
lowest published toxic dose: 192 mg/kg (6 day after birth)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) | Reproductive: Effects on newborn: Physical Reproductive: Effects on newborn: Delayed effects
ENVRAL 31,76,1983
|
oral | rat
lowest published toxic dose: 148 mg/kg (6-21 day pregnant/21 day after birth)
|
Reproductive: Effects on newborn: Behavioral
|
FAATDF 33,120,1996
|
oral | rat
lowest published toxic dose: 35 mg/kg (10-16 day pregnant)
|
Reproductive: Effects on newborn: Biochemical and metabolic
|
TXAPA9 139,252,1996
|
oral | rat
lowest published toxic dose: 90 mg/kg (7-15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Hepatobiliary system
|
FCTXAV 11,471,1973
|
oral | rat
lowest published toxic dose: 40 mg/kg (5 day after birth)
|
Reproductive: Effects on newborn: Delayed effects
|
BECTA6 38,946,1987
|
oral | rat
lowest published toxic dose: 750 mg/kg (5 day male)
|
Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea)
|
FCTXAV 13,507,1975
|
oral | rat
lowest published toxic dose: 96 mg/kg (6-21 day pregnant)
|
Reproductive: Effects on newborn: Behavioral
|
BRREAP 850,87,1999
|
oral | rat
lowest published toxic dose: 304 mg/kg (6-22 day pregnant/21 day after birth)
|
Reproductive: Effects on newborn: Other postnatal measures or effects
|
HERED3 144,196,2000
|
oral | rat
lowest published toxic dose: 380 mg/kg (6-22 day pregnant/21 day after birth)
|
Reproductive: Specific developmental abnormalities: Endocrine system
|
TOXID9 15,243,1995
|
oral | rat
lowest published toxic dose: 38 mg/kg (6-22 day pregnant/21 day after birth)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Specific developmental abnormalities: Endocrine system
TOXID9 15,157,1995
|
oral | rat
lowest published toxic dose: 152 mg/kg (6-22 day pregnant/21 day after birth)
|
Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth) | Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
TOXID9 15,157,1995
|
oral | rat
lowest published toxic dose: 38 mg/kg (6-22 day pregnant/21 day after birth)
|
Reproductive: Specific developmental abnormalities: Eye, ear
|
TOXID9 30,25,1996
|
oral | rat
lowest published toxic dose: 35 mg/kg (10-16 day pregnant)
|
Reproductive: Specific developmental abnormalities: Endocrine system
|
TXAPA9 136,269,1996
|
oral | rat
lowest published toxic dose: 320 µg/kg (5 day after birth)
|
Reproductive: Specific developmental abnormalities: Hepatobiliary system | Reproductive: Specific developmental abnormalities: Urogenital system
ENVRAL 66,52,1994
|
oral | rat
lowest published toxic dose: 160 µg/kg (5 day after birth)
|
Reproductive: Effects on newborn: Physical
|
ENVRAL 66,52,1994
|
oral | rat
lowest published toxic dose: 222 mg/kg (6-22 day pregnant/21 day after birth)
|
Reproductive: Specific developmental abnormalities: Central nervous system
|
TXAPA9 174,188,2001
|
oral | rat
lowest published toxic dose: 462.5 mg/kg (1 day pregnant-15 day after birth)
|
Reproductive: Specific developmental abnormalities: Hepatobiliary system | Reproductive: Specific developmental abnormalities: Endocrine system Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
BECTA6 48,715,1992
|
oral | rat
lowest published toxic dose: 4 gm/kg (12-16 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system
|
TJADAB 21,62A,1980
|
oral | rat
lowest published toxic dose: 396 mg/kg (28 day prior to copulation-16 day after birth)
|
Reproductive: Specific developmental abnormalities: Gastrointestinal system | Reproductive: Specific developmental abnormalities: Immune and reticuloendothelial system Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
TOSCF2 77,315,2004
|
oral | rat
lowest published toxic dose: 228 mg/kg (6-22 day pregnant/21 day after birth)
|
Reproductive: Specific developmental abnormalities: Eye, ear | Reproductive: Effects on newborn: Delayed effects
TOSCF2 68,458,2002
|
oral | rat
lowest published toxic dose: 675 mg/kg (1-22 day pregnant/23 day after birth)
|
Reproductive: Other effects on female | Reproductive: Specific developmental abnormalities: Endocrine system Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
TOSCF2 77,51,2004
|
oral | rabbit
lowest published toxic dose: 350 mg/kg (1-28 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on fertility: Abortion Reproductive: Effects on embryo or fetus: Fetal death
EVPHBI 1,67,1971
|
oral | rabbit
lowest published toxic dose: 280 mg/kg (1-28 day pregnant)
|
Reproductive: Effects on newborn: Biochemical and metabolic
|
BECTA6 6,120,1971
|
subcutaneous | mouse
lowest published toxic dose: 300 mg/kg (14 day prior to copulation)
|
Reproductive: Specific developmental abnormalities: Immune and reticuloendothelial system | Reproductive: Effects on newborn: Biochemical and metabolic Reproductive: Effects on newborn: Other postnatal measures or effects
AECTCV 44,72,2003
|
subcutaneous | rat
lowest published toxic dose: 90 mg/kg (10-18 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Specific developmental abnormalities: Endocrine system
TOLED5 135,S83,2001
|
subcutaneous | rat
lowest published toxic dose: 270 mg/kg (10-18 day pregnant)
|
Reproductive: Specific developmental abnormalities: Urogenital system
|
TOXID9 72,133,2003
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | mouse
lowest published toxic dose: 500 mg/kg (19 day pregnant)
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Reproductive: Tumorigenic effects: Transplacental tumorigenesis Lung, Thorax, or Respiration: Tumors
JJIND8 71,157,1983
|
oral | mouse
lowest published toxic dose: 17 gm/kg/48 week- continuous
|
Tumorigenic: Neoplastic by RTECS criteria | Liver: Tumors
JNCIAM 53,547,1974
|
oral | rat
lowest published toxic dose: 73,500 mg/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors
EVHPAZ 60,89,1985
|
oral | rat
toxic dose : 1 mg/kg
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Gastrointestinal: Tumors
CNREA8 41,5052,1981
|
oral | rat
toxic dose : 3 mg/kg
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Gastrointestinal: Tumors
CNREA8 41,5052,1981
|
oral | rat
toxic dose : 4 gm/kg/2 year- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Gastrointestinal: Tumors Liver: Tumors
NCITR* NCI-TR-38,1978
|
skin | mouse
lowest published toxic dose: 4 mg/kg
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Skin and Appendages: Tumors Tumorigenic: Tumors at site of application
BECTA6 18,552,1977
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | mammal (species unspecified)
lethal dose (50 percent kill): >1,250 mg/kg
|
N/R
|
AECTCV 6,279,1977
|
intraperitoneal | mouse
lethal dose (50 percent kill): 880 mg/kg
|
N/R
|
BECTA6 8,245,1972
|
intraperitoneal | mouse
lowest published toxic dose: 50 mg/kg
|
Liver: Changes in liver weight | Endocrine: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
ENVPAF 72,57,1991
|
intraperitoneal | mouse
lowest published toxic dose: 200 mg/kg
|
Liver: Other changes | Blood: Other changes
ENVPAF 72,57,1991
|
intraperitoneal | mouse
lowest published toxic dose: 50 mg/kg
|
Blood: Other changes
|
ENVPAF 72,57,1991
|
intraperitoneal | mouse
lowest published toxic dose: 200 mg/kg
|
Endocrine: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
ENVPAF 72,57,1991
|
intraperitoneal | mouse
lowest published toxic dose: 500 mg/kg
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
TXAPA9 71,254,1983
|
intraperitoneal | non-mammalian species
lowest published toxic dose: 20 mg/kg
|
Liver: Liver function tests impaired | Liver: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other transferases
TOLED5 136,97,2002
|
intraperitoneal | non-mammalian species
lowest published toxic dose: 70 mg/kg
|
Kidney, Ureter, and Bladder: Other changes | Biochemical: Metabolism (intermediary): Other proteins
TOLED5 136,97,2002
|
intraperitoneal | rat
lowest published toxic dose: 500 mg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
|
MOPMA3 13,924,1977
|
intraperitoneal | rat
lowest published toxic dose: 10 mg/kg
|
Endocrine: Evidence of thyroid hypofunction
|
ARTODN Suppl.13,440,1989
|
intravenous | chicken
lowest published toxic dose: 300 mg/kg
|
Kidney, Ureter, and Bladder: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Cytochrome oxidases (indlucing oxidative phosphrylation) Biochemical: Metabolism (intermediary): Effect on mitochondrial function
JBCHA3 255,8275,1980
|
intravenous | rat
lethal dose (50 percent kill): 358 mg/kg
|
Behavioral: Somnolence (general depressed activity) | Lung, Thorax, or Respiration: Dyspnea Gastrointestinal: Hypermotility, diarrhea
FCTXAV 12,63,1974
|
intravenous | rat
lethal dose (50 percent kill): 358 mg/kg
|
N/R
|
VCVGK* -,58,1984
|
oral | mammal (species unspecified)
lethal dose (50 percent kill): 4 gm/kg
|
N/R
|
AECTCV 6,279,1977
|
oral | rat
lethal dose (50 percent kill): 1,010 mg/kg
|
N/R
|
TXAPA9 60,33,1981
|
oral | rat
lowest published toxic dose: 300 mg/kg
|
Liver: Other changes | Endocrine: Evidence of thyroid hypofunction Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
EVHPAZ 109,1163,2001
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intramuscular | domestic animal
lowest published toxic dose: 5 mg/kg/20 day- intermittent
|
Liver: Other changes
|
JEPOEC 12,17,1993
|
intramuscular | domestic animal
lowest published toxic dose: 7,500 µg/kg/12 week- intermittent
|
Liver: Other changes
|
JEPOEC 12,17,1993
|
intramuscular | rabbit
lowest published toxic dose: 25 mg/kg/20 day- intermittent
|
Liver: Other changes
|
JEPOEC 12,17,1993
|
intraperitoneal | wild bird
lowest published toxic dose: 320 mg/kg/13 day- intermittent
|
Endocrine: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Cytochrome oxidases (indlucing oxidative phosphrylation) Biochemical: Metabolism (intermediary): Other
CBCPAI 99C,251,1991
|
intraperitoneal | guinea pig
lowest published toxic dose: 320 mg/kg/13 day- intermittent
|
Endocrine: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Cytochrome oxidases (indlucing oxidative phosphrylation) Biochemical: Metabolism (intermediary): Other
CBCPAI 99C,251,1991
|
intraperitoneal | non-mammalian species
lowest published toxic dose: 320 mg/kg/13 day- intermittent
|
Endocrine: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Cytochrome oxidases (indlucing oxidative phosphrylation) Biochemical: Metabolism (intermediary): Other
CBCPAI 99C,251,1991
|
intraperitoneal | rat
lowest published toxic dose: 350 mg/kg/7 day- intermittent
|
Liver: Other changes | Liver: Changes in liver weight Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes
JTEHD6 4,107,1978
|
intraperitoneal | rat
lowest published toxic dose: 50 mg/kg/2 week- intermittent
|
Biochemical: Metabolism (intermediary): Other
|
BECTA6 19,729,1978
|
intraperitoneal | rat
lowest published toxic dose: 60 mg/kg/30 day- intermittent
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Related to Chronic Data: Changes in testicular weight
REPTED 19,201,2004
|
intraperitoneal | rat
lowest published toxic dose: 60 mg/kg/30 day- intermittent
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Catalases
REPTED 19,201,2004
|
oral | domestic bird
lowest published toxic dose: 431 mg/kg/8 week- continuous
|
Autonomic Nervous System: Sympathomimetic | Liver: Changes in liver weight Biochemical: Neurotransmitters or modulators (putative): Dopamine at other sites
TXAPA9 53,75,1980
|
oral | wild bird
lowest published toxic dose: 2,800 mg/kg/8 week- intermittent
|
Endocrine: Changes in thyroid weight
|
BECTA6 8,306,1972
|
oral | mammal (species unspecified)
lowest published toxic dose: 119 mg/kg/28 day- continuous
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
AECTCV 15,393,1986
|
oral | mammal (species unspecified)
lowest published toxic dose: 180 mg/kg/17 week- continuous
|
Cardiac: Changes in heart weight | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
AECTCV 6,279,1977
|
oral | monkey
lowest published toxic dose: 8,365 µg/kg/4.5 year- intermittent
|
Immunological Including Allergic: Decrease in humoral immune response
|
FAATDF 16,773,1991
|
oral | monkey
lowest published toxic dose: 170 mg/kg/2.3 year- intermittent
|
Eye: Other eye effects | Blood: Changes in spleen Skin and Appendages: Other: Nails
TOPADD 14,1,1986
|
oral | monkey
lowest published toxic dose: 14.6 mg/kg/2 year- intermittent
|
Endocrine: Other changes
|
AECTCV 19,939,1990
|
oral | monkey
lowest published toxic dose: 58.4 mg/kg/2 year- intermittent
|
Endocrine: Effect on menstrual cycle
|
AECTCV 19,939,1990
|
oral | mouse
lowest published toxic dose: 672 mg/kg/28 day- continuous
|
Liver: Changes in liver weight
|
JTEHD6 5,605,1979
|
oral | mouse
lowest published toxic dose: 90 mg/kg/15 day- continuous
|
Behavioral: Altered sleep time (including change in righting reflex) | Liver: Changes in liver weight Endocrine: Changes in adrenal weight
TXAPA9 40,91,1977
|
oral | mouse
lowest published toxic dose: 178 mg/kg/14 day- continuous
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
BECTA6 12,394,1974
|
oral | mouse
lowest published toxic dose: 552 mg/kg/14 day- continuous
|
Behavioral: Altered sleep time (including change in righting reflex) | Liver: Changes in liver weight
BECTA6 12,394,1974
|
oral | mouse
lowest published toxic dose: 1,965 mg/kg/14 day- continuous
|
Endocrine: Changes in adrenal weight
|
BECTA6 12,394,1974
|
oral | mouse
lowest published toxic dose: 3,360 mg/kg/7 day- continuous
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
|
BECTA6 12,394,1974
|
oral | mouse
lowest published toxic dose: 168 mg/kg/2 week- continuous
|
Behavioral: Altered sleep time (including change in righting reflex) | Liver: Changes in liver weight
ENPBBC 5,308,1975
|
oral | mouse
lowest published toxic dose: 672 mg/kg/2 week- continuous
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | Reproductive: Paternal effects: Prostate, seminal vesicle, Cowper's gland, accessory glands
ENPBBC 5,308,1975
|
oral | mouse
lowest published toxic dose: 75.6 mg/kg/21 day- intermittent
|
Liver: Changes in liver weight | Endocrine: Evidence of thyroid hypofunction Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other transferases
TXAPA9 188,6,2003
|
oral | non-mammalian species
lowest published toxic dose: 102.9 mg/kg/30 day- continuous
|
Endocrine: Androgenic | Endocrine: Estrogenic Related to Chronic Data: Changes in ovarian weight
MAERE* 24,179,1988
|
oral | non-mammalian species
lowest published toxic dose: 30 mg/kg/30 day- continuous
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes
BIREBV 64,955,2001
|
oral | non-mammalian species
lowest published toxic dose: 30 mg/kg/15 day- continuous
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes
BIREBV 64,955,2001
|
oral | quail
lowest published toxic dose: 588 mg/kg/12 week- intermittent
|
Liver: Other changes | Biochemical: Metabolism (intermediary): Porphyrin including bile pigments
JTEHD6 51,57,1997
|
oral | rat
lowest published toxic dose: 600 mg/kg/4 week- intermittent
|
Behavioral: Change in motor activity (specific assay) | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
FAATDF 40,68,1997
|
oral | rat
lowest published toxic dose: 5,475 mg/kg/52 week- continuous
|
Liver: Other changes | Biochemical: Metabolism (intermediary): Lipids including transport Biochemical: Metabolism (intermediary): Other proteins
AECTCV 8,191,1979
|
oral | rat
lowest published toxic dose: 1,652 mg/kg/35 week- continuous
|
Liver: Other changes | Liver: Changes in liver weight
AEHLAU 25,354,1972
|
oral | rat
lowest published toxic dose: 210 mg/kg/20 week- continuous
|
Liver: Changes in liver weight | Biochemical: Metabolism (intermediary): Lipids including transport
TXAPA9 37,112,1976
|
oral | rat
lowest published toxic dose: 105 mg/kg/15 week- intermittent
|
Liver: Changes in liver weight | Kidney, Ureter, and Bladder: Changes in bladder weight Musculoskeletal: Other changes
TXCYAC 57,83,1989
|
oral | rat
lowest published toxic dose: 50,400 µg/kg/12 week- continuous
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) Biochemical: Metabolism (intermediary): Other proteins
BECTA6 12,669,1974
|
oral | rat
lowest published toxic dose: 60 mg/kg/20 day- continuous
|
Liver: Changes in liver weight | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
JTEHD6 3,769,1977
|
oral | rat
lowest published toxic dose: 70 mg/kg/1 week- intermittent
|
Liver: Changes in liver weight | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
BECTA6 12,145,1974
|
oral | rat
lowest published toxic dose: 1,920 µg/kg/4 day- continuous
|
Liver: Changes in liver weight | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Metabolism (intermediary): Lipids including transport
BECTA6 34,427,1985
|
oral | rat
lowest published toxic dose: 1,820 mg/kg/52 week- continuous
|
Behavioral: Food intake (animal) | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TOSCF2 53,377,2000
|
oral | rat
lowest published toxic dose: 1,750 mg/kg/10 week- intermittent
|
Endocrine: Changes in pituitary weight | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
FAATDF 20,288,1993
|
oral | rat
lowest published toxic dose: 2,625 mg/kg/15 week- intermittent
|
Endocrine: Changes in pituitary weight | Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) Nutritional and Gross Metabolic: Weight loss or decreased weight gain
FAATDF 20,288,1993
|
oral | rat
lowest published toxic dose: 35 mg/kg/5 week- intermittent
|
Liver: Other changes | Kidney, Ureter, and Bladder: Other changes Endocrine: Evidence of thyroid hypofunction
FAATDF 20,288,1993
|
oral | rat
lowest published toxic dose: 300 mg/kg/30 day- intermittent
|
Endocrine: Effect on menstrual cycle | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
CBCPAI 77C ,65,1984
|
oral | rat
lowest published toxic dose: 632.4 mg/kg/372 day- continuous
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
TOSCF2 53,377,2000
|
oral | rat
lowest published toxic dose: 1,055.6 mg/kg/182 day- continuous
|
Musculoskeletal: Other changes
|
TOSCF2 53,377,2000
|
oral | rat
lowest published toxic dose: 309.4 mg/kg/182 day- continuous
|
Behavioral: Change in motor activity (specific assay)
|
TOSCF2 53,377,2000
|
oral | rat
lowest published toxic dose: 750 mg/kg/5 day- intermittent
|
Blood: Changes in bone marrow not included in above | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
BECTA6 13,14,1975
|
oral | rat
lowest published toxic dose: 1,500 mg/kg/5 day- intermittent
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
|
BECTA6 13,14,1975
|
oral | rat
lowest published toxic dose: 10 mg/kg/40 day- continuous
|
Endocrine: Evidence of thyroid hypofunction
|
ENDOAO 121,520,1987
|
oral | rat
lowest published toxic dose: 10 mg/kg/20 day- continuous
|
Endocrine: Evidence of thyroid hypofunction
|
ENDOAO 121,520,1987
|
oral | rat
lowest published toxic dose: 7.5 mg/kg/150 day- continuous
|
Biochemical: Metabolism (intermediary): Other
|
ENDOAO 121,520,1987
|
oral | rat
lowest published toxic dose: 8.4 mg/kg/4 week- continuous
|
Endocrine: Evidence of thyroid hyperfunction
|
VAAZA2 33,213,1980
|
oral | rat
lowest published toxic dose: 84 mg/kg/4 week- continuous
|
Endocrine: Toxic goiter- hypofunction
|
VAAZA2 33,213,1980
|
oral | rat
lowest published toxic dose: 10.5 mg/kg/5 week- continuous
|
Endocrine: Other changes
|
JEPTDQ 1,587,1978
|
oral | rat
lowest published toxic dose: 756 mg/kg/18 week- continuous
|
Liver: Tumors | Tumorigenic: Facilitates action of known carcinogens
JNCIAM 66,509,1981
|
oral | rat
lowest published toxic dose: 165 mg/kg/11 day- intermittent
|
Liver: Changes in liver weight | Biochemical: Metabolism (intermediary): Other
CJPPA3 54,23,1976
|
oral | rat
lowest published toxic dose: 21 mg/kg/7 day- continuous
|
Liver: Changes in liver weight | Endocrine: Evidence of thyroid hyperfunction Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases
ATSUDG 12,85,1988
|
oral | rat
lowest published toxic dose: 63 mg/kg/7 day- continuous
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases
|
ATSUDG 12,85,1988
|
oral | rat
lowest published toxic dose: 33.6 mg/kg/28 day- continuous
|
Liver: Fatty liver degeneration | Endocrine: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
JTEHD6 6,421,1980
|
oral | rat
lowest published toxic dose: 350 mg/kg/7 day- intermittent
|
Liver: Changes in liver weight | Reproductive: Paternal effects: Testes, epididymis, sperm duct Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases
EXMPA6 22,376,1975
|
oral | rat
lowest published toxic dose: 42 mg/kg/7 day- continuous
|
Endocrine: Evidence of thyroid hypofunction | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other transferases
TOXID9 72,313,2003
|
oral | rat
lowest published toxic dose: 56 mg/kg/14 day- intermittent
|
Endocrine: Evidence of thyroid hypofunction | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
TXCYAC 177,227,2002
|
oral | rat
lowest published toxic dose: 42 mg/kg/7 day- intermittent
|
Liver: Changes in liver weight | Endocrine: Evidence of thyroid hypofunction
TOSCF2 65,184,2002
|
oral | rabbit
lowest published toxic dose: 4,200 mg/kg/14 week- intermittent
|
Liver: Changes in liver weight | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases Related to Chronic Data: Changes in uterine weight
AJPAA4 70,363,1973
|
oral | rabbit
lowest published toxic dose: 5.94 mg/kg/33 day- continuous
|
Immunological Including Allergic: Decrease in humoral immune response
|
TXAPA9 32,587,1975
|
oral | rabbit
lowest published toxic dose: 10.26 mg/kg/57 day- continuous
|
Endocrine: Other changes
|
TXAPA9 32,587,1975
|
oral | rabbit
lowest published toxic dose: 119.7 mg/kg/57 day- continuous
|
Liver: Changes in liver weight | Endocrine: Changes in spleen weight
TXAPA9 32,587,1975
|
parenteral | duck
lowest published toxic dose: 25 mg/kg/10 week- intermittent
|
Liver: Other changes
|
JEPOEC 12,17,1993
|
subcutaneous | domestic animal
lowest published toxic dose: 20 mg/kg/20 day- intermittent
|
Immunological Including Allergic: Decrease in humoral immune response | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
JEPOEC 9,283,1989
|
subcutaneous | rabbit
lowest published toxic dose: 25 mg/kg/20 day- intermittent
|
Lung, Thorax, or Respiration: Other changes | Kidney, Ureter, and Bladder: Other changes Biochemical: Metabolism (intermediary): Other proteins
JEPOEC 9,283,1989
|
skin | rat
lowest published toxic dose: 120 µg/kg/4 day- intermittent
|
Liver: Changes in liver weight | Biochemical: Metabolism (intermediary): Other
CJPPA3 54,23,1976
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
time-weighted average 0.5 mg/m3 (skin)
|
DTLVS* TLV/BEI,2003
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
Confirmed Animal Carcinogen with Unknown
|
DTLVS* TLV/BEI,2003
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Limited Evidence
|
IMEMDT 18,43,1978
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMSUDL 7,322,1987
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 2A
|
IMSUDL 7,322,1987
|
TOXICOLOGY REVIEW
|
|
EVHPAZ 1,105,1972
|
TOXICOLOGY REVIEW
|
|
ARVPAX 14,139,1974
|
TOXICOLOGY REVIEW
|
|
RREVAH 44,1,1973
|
TOXICOLOGY REVIEW
|
|
STEVA8 2,305,1974
|
TOXICOLOGY REVIEW
|
|
BISNAS 20,958,1970
|
TOXICOLOGY REVIEW
|
|
ENVRAL 5,249,1972
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Mine Safety and Health Administration (MSHA) STANDARD - air
|
time-weighted average 0.5 mg/m3 (skin)
|
DTLVS* 3,52,1971
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry)
|
8 hour time-weighted average 0.5 mg/m3 (skin)
|
CFRGBR 29,1910.1000,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction)
|
8 hour time-weighted average 0.5 mg/m3 (skin)
|
CFRGBR 29,1926.55,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards)
|
8 hour time-weighted average 0.5 mg/m3 (skin)
|
CFRGBR 29,1915.1000,1993
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors)
|
8 hour time-weighted average 0.5 mg/m3 (skin)
|
CFRGBR 41,50-204.50,1994
|
Occupational Exposure Limit - AUSTRALIA
|
time-weighted average 0.5 mg/m3, short term exposure limit 1 mg/m3, Skin, Carcinogen JAN1993
|
Occupational Exposure Limit - AUSTRIA
|
MAK 0.05 ppm (0.5 mg/m3), Skin, Suspected Carcinogen, JAN1999
|
Occupational Exposure Limit - BELGIUM
|
time-weighted average 0.5 mg/m3, short term exposure limit 1 mg/m3, Skin, JAN1993
|
Occupational Exposure Limit - FRANCE
|
VME 0.5 mg/m3, Skin, JAN1999
|
Occupational Exposure Limit - GERMANY
|
MAK 0.05 ppm (0.5 mg/m3), Skin, Carcinogen, JAN1999
|
Occupational Exposure Limit - JAPAN
|
Occupational Exposure Limit 0.1 mg/m3, Skin, 2A Carcinogen, JAN1999
|
Occupational Exposure Limit - NORWAY
|
time-weighted average 0.01 mg/m3, JAN1999
|
Occupational Exposure Limit - THE NETHERLANDS
|
MAC-TGG 0.5 mg/m3, Skin, 2003
|
Occupational Exposure Limit - POLAND
|
MAC(time-weighted average) 1 mg/m3, JAN1999
|
Occupational Exposure Limit - SWEDEN
|
NGV 0.1 mg/m3, KTV 0.3 mg/m3, Skin, Carcinogen, JAN1999
|
Occupational Exposure Limit - SWITZERLAND
|
MAK- week 0.05 ppm (0.5 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - TURKEY
|
time-weighted average 1 mg/m3, Skin, JAN1993
|
Occupational Exposure Limit - UNITED KINGDOM
|
time-weighted average 0.1 mg/m3, Skin, SEP2000
|
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value; | Confirmed Animal Carcinogen with Unknown
Occupational Exposure Limit IN NEW ZEALAND, SINGAPORE, VIETNAM
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value |
Confirmed Animal Carcinogen with Unknown |
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO CHLORODIPHENYL (54% Cl)-air
|
Carcinogen; | 10 hour time-weighted average 0.001 mg/m3
NIOSH* DHHS #92-100,1992
|
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: X1181; |
Number of Industries 5; Total Number of Facilities 170; Number of Occupations 7; Total Number of Employees Exposed 3,702; Total Number of Female Employees Exposed 1,725 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
ATSDR TOXICOLOGY PROFILE (NTIS** PB/2000/108027)
|
EPA GENETOX PROGRAM 1988, Negative: SHE-clonal assay; Rodent dominant lethal
|
EPA GENETOX PROGRAM 1988, Negative: Sperm morphology-mouse
|
EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus
|
Used in heat transfer and hydraulic fluids, and lubricants, and insecticide formulations
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
On EPA IRIS database
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NIOSH CURRENT INTELLIGENCE BULLETIN 7, 1976 AND BULLETIN 45, 1986
|
NIOSH Analytical Method, 1994: Polychlorobiphenyls, 5503; in serum, 8004
|
NCI Carcinogenesis Bioassay (feed);equivocal evidence:rat
|
NCITR* NCI-TR-38,1978
|
NTP 11th Report on Carcinogens,2004:Reasonably anticipated to be a human carcinogen
|
|
REFERENCES:
CODEN
|
|
REFERENCE
AECTCV
|
Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc.,
Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973-
|
AEHLAU
|
Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC
20016) V.1- 1960-
|
AJPAA4
|
American Journal of Pathology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia
Ave., Hagerstown, MD 21740) V.1- 1925-
|
ARTODN
|
Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep.
Ger.) V.32- 1974-
|
ARVPAX
|
Annual Review of Pharmacology. (Palo Alto, CA) V.1-15, 1961-75. For publisher information,
see ARPTDI.
|
ATSUDG
|
Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz
Way, Secaucus, NJ 07094) No.1- 1978-
|
BECTA6
|
Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc.,
Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966-
|
BIREBV
|
Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL
61820) V.1- 1969-
|
BISNAS
|
BioScience. (American Institute of Biological Sciences, 1401 Wilson Blvd., Arlington, VA
22209) V.14- 1964-
|
BRREAP
|
Brain Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1966-
|
BSIBAC
|
Bolletino della Societe Italiana di Biologia Sperimentale. (Casa Editrice Idelson, Via A. de
Gasperi, 55, 80133 Naples, Italy) V.2- 1927-
|
CBCPAI
|
Comparative Biochemistry and Physiology. (Elmsford, NY) V.1-37, 1960-70. For publisher
information, see CBPBB8.
|
CBPCEE
|
Comparative Biochemistry and Physiology, C: Pharmacology, Toxicology and Endocrinology.
(Elsevier Science, 660 White Plains Rd., Tarrytown, NY 10591) V.74- 1983-
|
CFRGBR
|
Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents,
Washington, DC 20402)
|
CJPPA3
|
Canadian Journal of Physiology and Pharmacology. (National Research Council of Canada,
Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.42- 1964-
|
CNREA8
|
Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA
19106) V.1- 1941-
|
CYTBAI
|
Cytobios. (Faculty Press, 88 Regent St., Cambridge, UK) V.1- 1969-
|
DTLVS*
|
The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by
American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
|
EMMUEG
|
Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
10003) V.10- 1987-
|
ENDOAO
|
Endocrinology (Baltimore). (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21203)
V.1- 1917-
|
ENPBBC
|
Environmental Physiology and Biochemistry. (Copenhagen, Denmark) V.2-5, 1972-75.
Discontinued.
|
ENVPAF
|
Environmental Pollution. (Barking, UK) V.1-20, 1970-79.
|
ENVRAL
|
Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-
1967-
|
EVHPAZ
|
EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents,
Washington, DC 20402) No.1- 1972-
|
EVPHBI
|
Environmental Physiology. (Copenhagen, Denmark) V.1(1-4), 1971. For publisher information,
see ENPBBC.
|
EXMPA6
|
Experimental and Molecular Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN
55802) V.1- 1962-
|
FAATDF
|
Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1-40, 1981-97. For publisher information, see TOSCF2
|
FCTXAV
|
Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see
FCTOD7.
|
HERED3
|
Hearing Research. (Elsevier Science B. V., POB 211, 1000 AE Amsterdam, Netherlands) V. 1-
1986-
|
IJBOBV
|
International Journal of Biochemistry. (Pergamon Press Inc., Maxwell House, Fairview Park,
Elmsford, NY 10523) V.1- 1970-
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
IMSUDL
|
IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY
12210) No.1- 1979-
|
JBCHA3
|
Journal of Biological Chemistry. (428 E. Preston St., Baltimore, MD 21202) V.1- 1905-
|
JEPOEC
|
Journal of Environmental Pathology, Toxicology and Oncology. (Chem-Orbital, POB 134, Park
Forest, IL 60466) V.5(4)- 1984-
|
JEPTDQ
|
Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3),
1977-81(?). For publisher information, see JEPOEC.
|
JJIND8
|
JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For
publisher information, see JNCIEQ.
|
JNCIAM
|
Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher
information, see JJIND8.
|
JTEHD6
|
Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW,
Washington, DC 20005) V.1- 1975/76-
|
MAERE*
|
Marine Environmental Research. (Kidlington, Oxford : Elsevier) V. 1- 1978-
|
MOPMA3
|
Molecular Pharmacology. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202)
V.1- 1965-
|
NCITR*
|
National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205.
For publisher information, see NTPTR*.
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
NRTXDN
|
Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979-
|
NTOTDY
|
Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher
information, see NETEEC.
|
REPTED
|
Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY
10523) V.1- 1987-
|
RREVAH
|
Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ
07094) V.1- 1962-
|
STEVA8
|
Science of the Total Environment. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam,
Netherlands) V.1- 1972-
|
SinJF#
|
Personal Communication from J.F. Sina, Merck Institute for Therapeutic Research, West Point,
PA 19486, Oct. 26, 1982
|
TJADAB
|
Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E.
11th St., New York, NY 10003) V.1- 1968-
|
TOLED5
|
Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands)
V.1- 1977-
|
TOPADD
|
Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical
Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978-
|
TOSCF2
|
Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 )
V. 41, Jan. 1998-
|
TOXID9
|
Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1-
1981-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
TXCYAC
|
Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973-
|
VAAZA2
|
Virchows Archiv, Abteilung B: Cell Pathology. (Springer-Verlag, Heidelberger Pl. 3, D-1000
Berlin 33, Fed. Rep. Ger.) V.1- 1968-
|
VCVGK*
|
"Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia".
(Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia,
1994.
|
|